University of Liverpool lead groundbreaking COVID-19 research programme

During this unprecedented global challenge, we’re proud to part of the support network to the University of Liverpool and their community of researchers who are at the forefront of this crisis to discover a solution to the COVID-19 pandemic and develop effective drug treatments and vaccines. The University’s team of researchers are vital in supporting the NHS, Liverpool and the world’s understanding of the biology of SARS-CoV-2, the virus that causes COVID-19.

An incredible £1.1m has been raised by the Health Protection Research Unit for Emerging Zoonotic Infections, the Centre of Excellence for Infectious Diseases, and a generous donation by the Alder Hey Charity. Work to be undertaken on the research programme has been strengthened by the University’s partnership with the Malawi-Liverpool-Wellcome Trust Clinical Research Programme.

The integrated approach to tackling the virus, alongside Liverpool Health Partners, has included making equipment such as oxygen compressors, student accommodation and University car parks available to NHS staff. Clinical academic and final-year medical students are taking positions in front-line medicine and thousands of medical students and staff volunteers are supporting in non-clinical areas such as assisting with food distribution across the city and childcare support for key workers.

We are proud to be part of the support network of partners to the University of Liverpool during such a challenging time.

Simon Keenan, University of Liverpool Alumni, Partner and Group Director at Griffiths & Armour said:

“We’re really proud of several of our clients who are at the forefront of the fight against COVID-19. The part we are playing is minor in the scheme of things, but we are committed to making sure any necessary flexibility and adjustments that need to happen to their insurance programme occur without delay to give the peace of mind that allows them to focus on the most important task – the groundbreaking COVID-19 research they are conducting.”